HLB Co., Ltd.
028300
Rang in Aktien
#4147
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Aktienkurs
$29.28
Marktkapitalisierung
$3.89B
Veränderung (1 Tag)
-1.40%
Veränderung (1 Jahr)
-8.45%
Land
KR
Handel HLB Co., Ltd. (028300)
Kategorie
Healthcare
P/S-Verhältnis für HLB Co., Ltd. (028300)
P/S-Verhältnis zum October 2026 TTM: 55.28
Laut den neuesten Finanzberichten und dem Aktienkurs von HLB Co., Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 55.28. Am Ende des Jahres 2023 lag das P/S-Verhältnis bei 150.34.
P/S-Verlauf für HLB Co., Ltd. von 2012 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 55.28 | -60.58% |
| 2024 | 140.24 | -6.72% |
| 2023 | 150.34 | 803.10% |
| 2022 | 16.65 | -69.56% |
| 2021 | 54.69 | -41.18% |
| 2020 | 92.98 | -26.04% |
| 2019 | 125.72 | 50.40% |
| 2018 | 83.59 | 18.72% |
| 2017 | 70.41 | 313.63% |
| 2016 | 17.02 | -13.10% |
| 2015 | 19.59 | 264.78% |
| 2014 | 5.37 | 94.50% |
| 2013 | 2.76 | 166.45% |
| 2012 | 1.04 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 10.02 | -81.87% |
US
|
|
| 40.55 | -26.65% |
US
|
|
| 3.96 | -92.83% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -81.65% |
NL
|
